Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | CIMAvax-EGF |
Synonyms | |
Therapy Description |
CIMAvax-EGF (EGF vaccine) is a cancer vaccine composed of EGF linked to the carrier protein P64, which induces an immune response against EGF, resulting in decreased EGF expression and has potential antitumor activity (PMID: 26927662, PMID: 27566188). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CIMAvax-EGF | CimaVax|CimaVax Vaccine|CIMAvax EGF | CIMAvax-EGF (EGF vaccine) is a cancer vaccine composed of EGF linked to the carrier protein Neisseria meningitidis-derived P64k, which induces an immune response against EGF, resulting in decreased EGF expression and has potential antitumor activity (PMID: 26927662, PMID: 27566188). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|